Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07641790 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Wearable Vibratory Devices on Arm Function in Subacute Stroke Patients

Study acronym: WEVIB-HEMI
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 11, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
University of Faisalabad
61 trials monitored
See 2 trials at risk
Stroke
3,531 trials monitored
See 153 trials at risk
Hemiplegia, or paralysis of one side of the body, often results from stroke and severely limits arm function. Standard physiotherapy helps, but recovery is often slow. This study tests if adding a wearable vibratory device to standard therapy improves arm movement better than standard therapy alone. Thirty patients with subacute stroke (3-6 months) will be split into two groups. One group will receive usual physiotherapy, while the other will receive usual physiotherapy plus the vibratory device for 8 weeks. Doctors will measure changes in spasticity (muscle stiffness), motor function, and daily independence before and after treatment.
Trial Details
NCT Number NCT07641790
Lead Sponsor University of Faisalabad
Conditions
(from sponsor)		 Hemiplegia, Stroke
Related terms Hemiplegia, Stroke
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov